FDA Calls On Drugmaker To Pull A Powerful Opioid Off The Market
The Food and Drug Administration says abuse of the painkiller Opana ER has fueled an outbreak of HIV, hepatitis C and a serious blood disorder, though it was reformulated to try to reduce abuse.